Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04625283 · ClinicalTrials.gov registry record · Phase 4
The Impact of Perioperative Ketamine Infusion on Surgical Recovery
A Phase 4 study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,570
- Enrollment target
NCT04625283 is a Phase 4 study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 1,570 participants.
The verdict
NCT04625283, a Phase 4 study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,570 participants
- Enrollment target
Study Summary
In order to effectively treat surgical pain with the least amount of opioids required, a multi-modal approach must include medications with different mechanisms of actions at alternative receptors. In light of the opioid epidemic, medical providers at Vanderbilt University Medical Center (VUMC) are strategically combining these medications in a bundled pain-regimen after surgery. These regimens have been shown to decrease opioid consumption, improve surgical outcomes, and reduce hospital stays, thus coining the term 'enhanced recovery pathway'. The combination of these medications has an indisputable synergistic effect. However, it is unknown how each medication contributes individually to the overall efficacy of the pathway. This study will examine the effects of ketamine, within the constructs of a multimodal pain regimen, on a) length of stay, b) opioid consumption, and c) surgical outcomes after major abdominal surgery.
Interventions
- DRUG Placebo
- DRUG Ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,570 participants |
| Start Date | 2021-04-12 |
| Est. Completion | 2024-02-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04625283
The ClinicalTrials.gov registry entry for NCT04625283 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,570 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04625283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04625283 about?
NCT04625283 is a clinical study titled "The Impact of Perioperative Ketamine Infusion on Surgical Recovery". In order to effectively treat surgical pain with the least amount of opioids required, a multi-modal approach must include medications with different mechanisms of actions at alternative receptors. In light of the opioid epidemic, medical providers at Vanderbilt University Medical Center (VUMC) are ...
What is the current status of trial NCT04625283?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,570 participants. The study started on 2021-04-12. Estimated completion is 2024-02-01.
What interventions are being tested in trial NCT04625283?
The interventions under investigation include: Placebo (DRUG), Ketamine (DRUG).
Who is sponsoring clinical trial NCT04625283?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.